Abbott announced that the Food and Drug Administration (FDA) has granted clearance for the i-STAT Total β-hCG blood test to detect if a woman is in the early stages of pregnancy.
This first-of-its-kind blood test is designed for use with the handheld, portable i-STAT System blood analyzer to rapidly detect human chorionic gonadotropin (hCG) hormone, which is usually used to determine whether a woman is pregnant. The test can measure very low levels of hCG in whole blood or plasma with only 2–3 drops of blood to provide high-quality results within 10 minutes.
RELATED: Preconception Low Dose Aspirin Could Help Some Women After Pregnancy Loss
The i-STAT Total β-hCG blood test can be used in a range of situations, including emergency settings, to guide decision-making by clinicians on medications, imaging, surgery, and other medical care.
For more information visit Abbott.com.